Kellanova Co (K) concluded trading on Thursday at a closing price of $81.56, with 2.89 million shares of worth about $235.57 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 38.35% during that period and on January 16, 2025 the price saw a gain of about 0.46%. Currently the company’s common shares owned by public are about 344.00M shares, out of which, 293.18M shares are available for trading.
Stock saw a price change of 0.02% in past 5 days and over the past one month there was a price change of 1.24%. Year-to-date (YTD), K shares are showing a performance of 0.73% which increased to 50.65% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $52.46 but also hit the highest price of $81.58 during that period. The average intraday trading volume for Kellanova Co shares is 1.97 million. The stock is currently trading 0.63% above its 20-day simple moving average (SMA20), while that difference is up 0.80% for SMA50 and it goes to 14.88% higher than SMA200.
Kellanova Co (NYSE: K) currently have 344.00M outstanding shares and institutions hold larger chunk of about 67.95% of that.
The stock has a current market capitalization of $28.11B and its 3Y-monthly beta is at 0.37. PE ratio of stock for trailing 12 months is 28.03, while it has posted earnings per share of $2.91 in the same period. Its PEG reads 3.35 and has Quick Ratio of 0.53 while making debt-to-equity ratio of 1.78. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for K, volatility over the week remained 0.34% while standing at 0.37% over the month.
Stock’s fiscal year EPS is expected to rise by 18.44% while it is estimated to increase by 4.13% in next year. EPS is likely to grow at an annualized rate of 8.36% for next 5-years, compared to annual growth of -6.41% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Exane BNP Paribas on November 01, 2024 offering a Neutral rating for the stock and assigned a target price of $83 to it. Stock get a Neutral rating from Goldman on August 12, 2024.
